Compounding Packaging White Paper 
Pharmaceutical Technology
JUNE 12, 2025
Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Give your business an edge with our leading industry insights.
Pharmaceutical Technology
JUNE 6, 2025
Ro5’s AI Chemistry Platform also uses advanced machine learning models and cheminformatics tools for quick compound discovery and design from hit identification to lead optimisation. Juvenescence CBE and CEO Dr Richard Marshall stated: “We are delighted to welcome the Ro5 team and the company’s capabilities into Juvenescence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 18, 2025
It recently initiated two more Phase III trials of its candidate CagriSema, as well as inking an $812m partnership with Deep Apple Therapeutics to access novel compounds, not GLP-1RAs, for obesity and other diseases. Give your business an edge with our leading industry insights.
Pharmaceutical Technology
FEBRUARY 23, 2023
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
Pharmaceutical Technology
JUNE 12, 2025
Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. The complexity of customs regulations also means lead times for shipping protract, which can have a negative impact on clinical trials and product availability.
European Pharmaceutical Review
DECEMBER 21, 2022
Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. EFPIA White Paper on Circular Economy, June 2020. Recycling of medical plastics.
Pharmaceutical Technology
JUNE 13, 2025
The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3 Give your business an edge with our leading industry insights.
Expert insights. Personalized for you.
59 
Let's personalize your content